Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Matthew P Deek, Kim Van der Eecken, Philip Sutera, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA Oncology
|
October 22, 2020
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate
Robert T Dess, Krithika Suresh, Michael J Zelefsky, et al.
European Urology
|
April 18, 2019
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
European Urology
|
January 30, 2023
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
Noah M Hahn, Michael A O'Donnell, Jason A Efstathiou, et al.
JAMA
|
March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Amar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
Sagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
European Urology
|
May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
Rebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
JAMA Oncology
|
January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
Amar U Kishan, Alison Steigler, James W Denham, et al.
JAMA Network Open
|
July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
Amar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Matthew P Deek, Kim Van der Eecken, Philip Sutera, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA Oncology
|
October 22, 2020
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate
Robert T Dess, Krithika Suresh, Michael J Zelefsky, et al.
European Urology
|
April 18, 2019
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
European Urology
|
January 30, 2023
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
Noah M Hahn, Michael A O'Donnell, Jason A Efstathiou, et al.
JAMA
|
March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Amar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
Sagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
European Urology
|
May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
Rebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
JAMA Oncology
|
January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
Amar U Kishan, Alison Steigler, James W Denham, et al.
JAMA Network Open
|
July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
Amar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
Page
of 9